The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome
Open accessAbstract
Summary Bisphenol A (BPA) is one of the most prevalent and best studied endocrine disruptors. After years of exposure to consumer products containing BPA, most individuals tested have circulating BPA at the low nanomolar levels. In addition to its well documented actions on the reproductive system, BPA exerts a wide variety of metabolic effects. This review summarizes recent findings on the ability of BPA, at environmentally relevant doses, to inhibit adiponectin and stimulate the release of inflammatory adipokines such as interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) from human adipose tissue. Expression of several classical and non-classical estrogen receptors in human adipose tissue raises the possibility of their involvement as mediators of BPA actions. The implications of these observations to the obesity-related metabolic syndrome and its sequalae are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“IL-6 is intimately involved with nflammatory states, hematopoiesis, immune responses and host efense mechanism (Heinrich et al., 2003).”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving
Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L., & Feldman, D. I. (1993) · Endocrinology · doi:10.1210/en.132.6.2279 · Cited by 1,613
Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,572
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Cited by
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1050 · Cited by 3,209
Bisphenol A and human health: A review of the literature
Rochester, J. R. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.08.008 · Cited by 2,018
Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects
Rubin, B. S. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.05.002 · Cited by 1,410
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
Endocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Recent advances in epoxy resin, natural fiber-reinforced epoxy composites and their applications
Saba, N., Jawaid, M., Alothman, O. Y., Paridah, M., & Hassan, A. (2016) · Journal of Reinforced Plastics and Composites · doi:10.1177/0731684415618459 · Cited by 487
Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease
Cimmino, I., Fiory, F., Perruolo, G., Miele, C., Beguinot, F., Formisano, P., & Oriente, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165761 · Cited by 478
The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity
vom Saal, F. S., Nagel, S. C., Coe, B. L., Angle, B. M., & Taylor, J. A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.001 · Cited by 450
Urinary bisphenol A and obesity: NHANES 2003–2006
Carwile, J. L., & Michels, K. B. (2011) · Environmental Research · doi:10.1016/j.envres.2011.05.014 · Cited by 371
Chakaroun, R., Massier, L., & Kovacs, P. (2020) · Nutrients · doi:10.3390/nu12041082 · Cited by 289
Meli, R., Monnolo, A., Annunziata, C., Pirozzi, C., & Ferrante, M. C. (2020) · Antioxidants · doi:10.3390/antiox9050405 · Cited by 288
Bisphenol A: An endocrine and metabolic disruptor
Fenichel, P., Chevalier, N., & Brucker-Davis, F. (2013) · Annales d'Endocrinologie · doi:10.1016/j.ando.2013.04.002 · Cited by 286
Sun, Q., Cornelis, M. C., Townsend, M. K., Tobias, D. K., Eliassen, A. H., Franke, A. A., Hauser, R., & Hu, F. B. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307201 · Cited by 274
Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity
Janesick, A., & Blumberg, B. (2011) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20197 · Cited by 269
Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
Palioura, E., & Diamanti-Kandarakis, E. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9326-7 · Cited by 161
“To be more specific, in human adipose depots BPA stimulates the release of cytokines favoring adiposity and insulin resistance namely Interleukin-6 (IL-6) and Tumor Necrosis Factor α (TNF-α) [56] whereas it inhibits the release of adiponectin that protects against metabolic syndrome [57].”
BackgroundImmune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health
Bansal, A., Henao-Mejia, J., & Simmons, R. A. (2018) · Endocrinology · doi:10.1210/en.2017-00882 · Cited by 152
Metadata
- Authors
- Ben-Jonathan, N., Hugo, E. R., & Brandebourg, T. D.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2009-05-25
- Volume
- 304
- Issue
- 1-2
- Pages
- 49-54
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2153112599
- Cited by
- 266
- References
- 70
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.